Literature DB >> 1991170

Mutations of the ras proto-oncogenes in childhood monosomy 7.

A Neubauer1, K Shannon, E Liu.   

Abstract

ras gene mutations are the most frequent molecular changes found in the preleukemic syndromes of adults and may play a role in initiating these diseases and in their progression to acute leukemia. However, little is known about the incidence or importance of these genetic mutations in childhood myeloproliferative states (MPS). The bone marrow (BM) monosomy 7 syndrome accounts for a large percentage of childhood MPS. Although the duration of the MPS is quite variable, children with monosomy 7 eventually develop acute myeloid leukemia (AML). We investigated 20 children (13 with MPS, 7 with AML) with BM monosomy 7 or 7q- for the presence of ras gene mutations using the polymerase chain reaction and hybridization with mutation-specific oligonucleotides. Mutations of N-ras and K-ras were detected in three children. Two patients carrying a ras mutation were in the myeloproliferative phase, and one had acute leukemia. All three patients with ras mutations either died of their disease or relapsed after BM transplantation as compared with 8 of 17 without ras mutations. However, this difference is not statistically significant (P = .14, not significant). We conclude that ras mutations are observed in childhood monosomy 7, though less frequently than in adult MDS, and may play a limited role in the progression of this disease to acute leukemia. More patients are needed to address the prognostic role of ras mutations in this rare disease.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1991170

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  6 in total

1.  Establishment of a monosomy 7 leukemia cell line, MONO-7, with a ras gene mutation.

Authors:  Hiroyuki Fujisaki; Kenji Takai; Sawada Akihisa; Sadao Tokimasa; Yoshiko Matsuda; Hideaki Ohta; Yuko Osugi; Ji Yoo Kim; Gaku Hosoi; Masahiro Sako; Junichi Hara
Journal:  Int J Hematol       Date:  2002-01       Impact factor: 2.490

2.  Use of chromosome engineering to model a segmental deletion of chromosome band 7q22 found in myeloid malignancies.

Authors:  Jasmine C Y Wong; Yan Zhang; Kenneth H Lieuw; Mary T Tran; Erna Forgo; Kelley Weinfurtner; Pilar Alzamora; Scott C Kogan; Keiko Akagi; Linda Wolff; Michelle M Le Beau; Nigel Killeen; Kevin Shannon
Journal:  Blood       Date:  2010-03-16       Impact factor: 22.113

3.  Retroviral integration at the Evi-2 locus in BXH-2 myeloid leukemia cell lines disrupts Nf1 expression without changes in steady-state Ras-GTP levels.

Authors:  D A Largaespada; J D Shaughnessy; N A Jenkins; N G Copeland
Journal:  J Virol       Date:  1995-08       Impact factor: 5.103

4.  Loss of the nf1 tumor suppressor gene decreases fas antigen expression in myeloid cells.

Authors:  Kelly Hiatt; David A Ingram; Hannah Huddleston; Dan F Spandau; Reuben Kapur; D Wade Clapp
Journal:  Am J Pathol       Date:  2004-04       Impact factor: 4.307

5.  Nf1 regulates hematopoietic progenitor cell growth and ras signaling in response to multiple cytokines.

Authors:  Y Y Zhang; T A Vik; J W Ryder; E F Srour; T Jacks; K Shannon; D W Clapp
Journal:  J Exp Med       Date:  1998-06-01       Impact factor: 14.307

Review 6.  Genetic predispositions and childhood cancer.

Authors:  K Shannon
Journal:  Environ Health Perspect       Date:  1998-06       Impact factor: 9.031

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.